RNAi therapeutic and its innovative biotechnological evolution

Y Weng, H Xiao, J Zhang, XJ Liang, Y Huang - Biotechnology advances, 2019 - Elsevier
Abstract Recently, United States Food and Drug Administration (FDA) and European
Commission (EC) approved Alnylam Pharmaceuticals' RNA interference (RNAi) therapeutic …
被引用次数：265 相关文章

RNAi therapeutic and its innovative biotechnological evolution

Y Weng, H Xiao, J Zhang, XJ Liang… - Biotechnology …, 2019 - pubmed.ncbi.nlm.nih.gov
Recently, United States Food and Drug Administration (FDA) and European Commission
(EC) approved Alnylam Pharmaceuticals' RNA interference (RNAi) therapeutic …

[引用][C] RNAi therapeutic and its innovative biotechnological evolution

Y Weng, H Xiao, J Zhang, XJ Liang, Y Huang - Biotechnology Advances, 2019 - cir.nii.ac.jp

RNAi therapeutic and its innovative biotechnological evolution.

Y Weng, H Xiao, J Zhang, XJ Liang… - Biotechnology …, 2019 - europepmc.org
Recently, United States Food and Drug Administration (FDA) and European Commission
(EC) approved Alnylam Pharmaceuticals' RNA interference (RNAi) therapeutic …

[引用][C] RNAi therapeutic and its innovative biotechnological evolution

Y Weng, H Xiao, J Zhang, XJ Liang, Y Huang - 2019